Cryo-Cell International, Inc.CCELNYSE
Loading
| Metric | Nov 21 | Nov 22 | Nov 23 |
|---|---|---|---|
| Revenue | 29 | 30 | 31 |
| Gross Profit | 20 | 22 | 23 |
| Operating Income | 4 | 4 | -12 |
| Net Income | 2 | 3 | -10 |
| EBITDA | 5 | 7 | -10 |
| EPS Diluted | 0.25 | 0.33 | -1.14 |
| Metric | Nov 21 | Nov 22 | Nov 23 |
|---|---|---|---|
| Cash & Equivalents | 8 | 2 | 0 |
| Total Current Assets | 16 | 10 | 9 |
| Total Assets | 61 | 65 | 61 |
| Total Current Liabilities | 21 | 19 | 21 |
| Total Liabilities | 56 | 66 | 72 |
| Total Equity | 4 | -2 | -11 |
| Total Debt | 3 | 12 | 11 |
| Net Debt | -5 | 10 | 10 |
| Metric | Nov 21 | Nov 22 | Nov 23 |
|---|---|---|---|
| Operating Cash Flow | 8 | 9 | 9 |
| Capital Expenditure | -7 | -17 | -8 |
| Free Cash Flow | 1 | -9 | 1 |
| Stock-Based Comp | 0 | 0 | 1 |
| Net Change in Cash | -2 | -7 | -1 |